DANIEL KIM, M.D.
Hematology & Oncology Physician · SOUTH PASADENA, CA
Individual Active NPI 1033291562
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 708 | 243,953 | $20,199,137 | $5,631,671 | $4,480,781 |
| 2023 | 629 | 225,866 | $18,203,736 | $5,043,149 | $4,001,100 |
| 2022 | 539 | 194,965 | $14,557,177 | $4,901,918 | $3,899,800 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0185 | Injection, aprepitant, 1 mg | 29,510 | $2 | $1 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 26,250 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 21,300 | $56 | $45 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 15,300 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,580 | $50 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 12,675 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 12,660 | $24 | $19 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,684 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,488 | $0 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 2,720 | $1 | $1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 2,640 | $0 | $0 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 1,954 | $4 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | A91209 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1174085492
- NPI 1235186354
- NPI 1164963583
- NPI 1346560786
- NPI 1316955230
- NPI 1609057157
- NPI 1396846432
- NPI 1720200363
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.